These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 26599623)

  • 21. Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.
    Angeloni V; Contessi N; De Marco C; Bertoldi S; Tanzi MC; Daidone MG; Farè S
    Acta Biomater; 2017 Nov; 63():306-316. PubMed ID: 28927931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
    Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
    Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
    Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics.
    Fitzgerald KA; Guo J; Tierney EG; Curtin CM; Malhotra M; Darcy R; O'Brien FJ; O'Driscoll CM
    Biomaterials; 2015 Oct; 66():53-66. PubMed ID: 26196533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
    Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
    Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
    Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
    Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.
    Bradford JR; Wappett M; Beran G; Logie A; Delpuech O; Brown H; Boros J; Camp NJ; McEwen R; Mazzola AM; D'Cruz C; Barry ST
    Oncotarget; 2016 Apr; 7(15):20773-87. PubMed ID: 26980748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer.
    Pecqueux C; Arslan A; Heller M; Falkenstein M; Kaczorowski A; Tolstov Y; Sültmann H; Grüllich C; Herpel E; Duensing A; Kristiansen G; Hohenfellner M; Navone NM; Duensing S
    Urol Oncol; 2018 Aug; 36(8):365.e15-365.e26. PubMed ID: 29887238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
    Mo F; Lin D; Takhar M; Ramnarine VR; Dong X; Bell RH; Volik SV; Wang K; Xue H; Wang Y; Haegert A; Anderson S; Brahmbhatt S; Erho N; Wang X; Gout PW; Morris J; Karnes RJ; Den RB; Klein EA; Schaeffer EM; Ross A; Ren S; Sahinalp SC; Li Y; Xu X; Wang J; Wang J; Gleave ME; Davicioni E; Sun Y; Wang Y; Collins CC
    Eur Urol; 2018 Apr; 73(4):524-532. PubMed ID: 28330676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro.
    Paindelli C; Navone N; Logothetis CJ; Friedl P; Dondossola E
    Biomaterials; 2019 Mar; 197():296-304. PubMed ID: 30682644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
    Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
    Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro design of mesenchymal to epithelial transition of prostate cancer metastasis using 3D nanoclay bone-mimetic scaffolds.
    Molla MS; Katti DR; Katti KS
    J Tissue Eng Regen Med; 2018 Mar; 12(3):727-737. PubMed ID: 28603879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMP4 promotes prostate tumor growth in bone through osteogenesis.
    Lee YC; Cheng CJ; Bilen MA; Lu JF; Satcher RL; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
    Cancer Res; 2011 Aug; 71(15):5194-203. PubMed ID: 21670081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer.
    Choudhary S; Ramasundaram P; Dziopa E; Mannion C; Kissin Y; Tricoli L; Albanese C; Lee W; Zilberberg J
    Sci Rep; 2018 Dec; 8(1):17975. PubMed ID: 30568232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis.
    Probert C; Dottorini T; Speakman A; Hunt S; Nafee T; Fazeli A; Wood S; Brown JE; James V
    Oncogene; 2019 Mar; 38(10):1751-1763. PubMed ID: 30353168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.
    Sung SY; Chang JL; Chen KC; Yeh SD; Liu YR; Su YH; Hsueh CY; Chung LW; Hsieh CL
    PLoS One; 2016; 11(4):e0153350. PubMed ID: 27054343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered colorectal cancer tissue recapitulates key attributes of a patient-derived xenograft tumor line.
    Hassani I; Anbiah B; Kuhlers P; Habbit NL; Ahmed B; Heslin MJ; Mobley JA; Greene MW; Lipke EA
    Biofabrication; 2022 Jul; 14(4):. PubMed ID: 35617932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
    Dorai T; Dutcher JP; Dempster DW; Wiernik PH
    Prostate; 2004 Jun; 60(1):1-17. PubMed ID: 15129424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.